Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract
AUTOR(ES)
Thaumaturgo, Nilton, Vilar, Mônica Magno, Diogo, Catia Maria, Edelenyi, Ricardo, Tendler, Miriam
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2001-09
RESUMO
In previous studies it was shown that the recombinant molecule, r-Sm14, induces high levels of protection against Schistosoma mansoni infection in two outbred animal models and immune crossprotection against infection by Fasciola hepatica in Swiss outbred mice. r-Sm14 was derived from a living worm extract, called SE, and is being developed as the molecular basis of an anti-helminth bivalent vaccine against the two parasites, for medical and veterinary application. Present data refer to SDS-PAGE and Western Blotting analysis of four different preparations of S. mansoni adult worms focusing Sm14 identification. The extracts correspond to the initial fraction of the SE extraction process, containing products released by living worms (SEi); SE2, reextraction of adult worms in PBS; and SE of separated male and female adult worms. In all extracts it was possible to detect the component of 14 kDa, that was recognized by specific anti-rSm14 antibody raised in rabbits.
Documentos Relacionados
- Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm
- Recombinant Mycobacterium bovis BCG Expressing the Sm14 Antigen of Schistosoma mansoni Protects Mice from Cercarial Challenge
- Sm14 of Schistosoma mansoni in Fusion with Tetanus Toxin Fragment C Induces Immunoprotection against Tetanus and Schistosomiasis in Mice
- Os efeitos da imunização com Sm14 recombinante (Sm14r) na redução da carga de vermes e na mortalidade de camundongos infectados com Schistosoma mansoni
- Avaliação da imunogenicidade de epitopos de células T das proteínas Sm14 e paramiosina do schistosoma mansoni em modelo murino.